federal_register: 2021-19220
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-19220 | Revision to Restrictions on Shipment or Use for Human Blood and Blood Components Exceptions; Technical Amendment | Rule | The Food and Drug Administration (FDA or we) is amending the biologics regulation to improve clarity and revise an incorrect citation. This action is being taken to ensure the accuracy and clarity of the biologics regulation. | 2021-09-07 | 2021 | 9 | https://www.federalregister.gov/documents/2021/09/07/2021-19220/revision-to-restrictions-on-shipment-or-use-for-human-blood-and-blood-components-exceptions | https://www.govinfo.gov/content/pkg/FR-2021-09-07/pdf/2021-19220.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA or we) is amending the biologics regulation to improve clarity and revise an incorrect citation. This action is being taken to ensure the accuracy and clarity of the biologics regulation. |